About CMC Bligny
"Le Centre Hospitalier de Bligny est un établissement privé à but non-lucratif, spécialisé en réadaptation cardiaque, réhabilitation respiratoire, hématologie, oncologie, diabétologie et maladies infectieuses. Il comporte un secteur de COURT SÉJOUR de médecine, ainsi qu'un secteur de SOINS DE SUITE ET RÉADAPTATION. Prenez contact."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
2
French Cardiology Society
2
GERCOR - Multidisciplinary Oncology Cooperative Group
2
Hoffmann-La Roche
2
Assistance Publique - Hôpitaux de Paris
1
Centre Hospitalier Universitaire Dijon
1
Centre Hospitalier de Bligny
1
Federation Francophone de Cancerologie Digestive
1
GCS IHFB Cognacq-Jay
1
UNICANCER
1
Clinical Trials at CMC Bligny
During the past decade, CMC Bligny conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer
1998-09-01
2005-09-01
Completed
36
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1998-10-01
Active, not recruiting
1,649
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
1999-01-01
Unknown status
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
2003-11-01
Unknown status
Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
2003-06-01
2011-01-01
Completed
282
Sleep Apnea Treatment During Cardiac Rehabilitation of Congestive Heart Failure Patients
2010-09-01
2014-12-01
Completed
300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CMC Bligny" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials, followed by "French Cardiology Society" with 2 trials
sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Assistance Publique - Hôpitaux de Paris"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CMC Bligny"
#1 collaborator was "Adep Assistance" with 1 trials as a collaborator, "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Fondation Francaise de Cancerologie Digestive" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at CMC Bligny
According to Clinical.Site data, the most researched conditions in "CMC Bligny" are
"Colorectal Cancer" (3 trials), "Pancreatic Cancer" (2 trials), "Anxiety" (1 trials), "Breast Cancer" (1 trials) and "COPD" (1 trials). Many other conditions were trialed in "CMC Bligny" in a lesser frequency.
Clinical Trials Intervention Types at CMC Bligny
Most popular intervention types in "CMC Bligny" are "Drug" (7 trials), "Other" (4 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "fluorouracil" (3 trials), "leucovorin calcium" (3 trials), "conventional surgery" (2 trials), "gemcitabine hydrochloride" (2 trials) and "oxaliplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CMC Bligny
The vast majority of trials in "CMC Bligny" are
13 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CMC Bligny
Currently, there are NaN active trials in "CMC Bligny".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in CMC Bligny,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CMC Bligny, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 4 trials that are defined as “Not Applicable".